101 related articles for article (PubMed ID: 8129380)
1. [Treatment of cancer and counter-measures for MRSA infections].
Tanaka K; Tokunaga N; Natori H; Oizumi K
Gan To Kagaku Ryoho; 1994 Mar; 21(4):409-16. PubMed ID: 8129380
[TBL] [Abstract][Full Text] [Related]
2. [Antibacteriological activities of arbekacin and vancomycin against strains of MRSA].
Ishii T; Takayama Y; Takase Y; Orikasa Y
Jpn J Antibiot; 1994 Jun; 47(6):647-54. PubMed ID: 8072173
[TBL] [Abstract][Full Text] [Related]
3. [Vancomycin and arbekacin, drugs of treatment for MRSA infections].
Kobayashi Y
Nihon Rinsho; 1992 May; 50(5):1054-9. PubMed ID: 1507428
[TBL] [Abstract][Full Text] [Related]
4. [Clinical studies on methicillin-resistant Staphylococcus aureus (MRSA) infections].
Okumura A; Muraishi Y; Tsuritani S; Sakamoto M; Kazama T; Fuse H; Katayama T
Hinyokika Kiyo; 1993 Dec; 39(12):1157-61. PubMed ID: 8285164
[TBL] [Abstract][Full Text] [Related]
5. [Treatment with arbekacin of surgical infections by resistant strains of Staphylococcus aureus. Arbekacin Study Group].
Morimoto K; Nakatani S; Kaji M; Kinoshita H; Fujimoto M; Hirata S; Ueda T; Tamate S; Yamazaki O
Jpn J Antibiot; 1994 Jun; 47(6):826-36. PubMed ID: 8072193
[TBL] [Abstract][Full Text] [Related]
6. [Clinical efficacy of arbekacin in deep MRSA infection. Including follow-up study after the termination of chemotherapy].
Kuwabara M; Konishi F; Yokoyama T; Kodama T; Santoh T; Nakai S; Miyoshi N; Kurimura T; Miyazawa T; Arita K
Jpn J Antibiot; 1994 Jun; 47(6):771-80. PubMed ID: 8072186
[TBL] [Abstract][Full Text] [Related]
7. [Clinical efficacy of arbekacin in patients with methicillin-resistant Staphylococcus aureus infections. Research Group of MRSA Forum].
Nasuhara K; Takatsuka K; Takatsuka N; Teraoka M; Tokita S; Shinohara M; Azuma E; Saijo N; Sone H; Saito I
Jpn J Antibiot; 1994 Jun; 47(6):720-30. PubMed ID: 8072180
[TBL] [Abstract][Full Text] [Related]
8. [Clinical efficacy of arbekacin on MRSA infections with hematopoietic disorders. The Hanshin Study Group of Hematopoietic Disorders and Infections].
Hamazaki H; Horiuchi A; Hasegawa H; Masaoka T; Kitani T; Kanayama Y; Sugiyama H; Tatsumi N; Kageyama T; Uchino H
Jpn J Antibiot; 1994 Jun; 47(6):763-70. PubMed ID: 8072185
[TBL] [Abstract][Full Text] [Related]
9. [Clinical efficacy of arbekacin on MRSA infections].
Ichiyama S; Shimokata K
Jpn J Antibiot; 1994 Jun; 47(6):731-5. PubMed ID: 8072181
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of arbekacin, a new aminoglycoside antibiotic, in surgical patients with MRSA infections].
Ishikawa S; Yura J; Shinagawa N; Mizuno A; Mashita K; Hori K
Jpn J Antibiot; 1994 Jun; 47(6):820-5. PubMed ID: 8072192
[TBL] [Abstract][Full Text] [Related]
11. [Clinical analysis of MRSA pneumonia. Niigata Research Group of MRSA.ABK].
Arakawa M; Wada K; Sega H; Yoshikawa H; Honma T; Miyao H; Shimazu Y; Tsukada H; Hoshino S; Sato S
Jpn J Antibiot; 1994 Jun; 47(6):736-40. PubMed ID: 8072182
[TBL] [Abstract][Full Text] [Related]
12. [Genomic DNA fingerprinting of arbekacin-resistant MRSA by pulsed-field gel electrophoresis].
Nonoyama M; Ida T; Hasobe T; Shimauchi C; Inoue M; Okamoto R; Okubo T
Jpn J Antibiot; 1994 Jun; 47(6):627-33. PubMed ID: 8072170
[TBL] [Abstract][Full Text] [Related]
13. [Nationwide investigation in Japan of the status of MRSA infections and usefulness of arbekacin].
Hayashi I; Inoue M; Hashimoto H
Jpn J Antibiot; 1994 Jun; 47(6):595-605. PubMed ID: 8072167
[TBL] [Abstract][Full Text] [Related]
14. [Clinical effect of arbekacin on MRSA infections after gastrointestinal surgery].
Ochiai M; Tanimura H; Noguchi K; Takifuji K; Konishi R; Ohkouchi N; Kouno N; Ohnishi H; Shimada K; Kasitani M
Jpn J Antibiot; 1994 Jun; 47(6):837-43. PubMed ID: 8072194
[TBL] [Abstract][Full Text] [Related]
15. Nationwide investigation in Japan on the efficacy of arbekacin in methicillin-resistant Staphylococcus aureus infections.
Hayashi I; Inoue M; Hashimoto H
Drugs Exp Clin Res; 1994; 20(6):225-32. PubMed ID: 7758394
[TBL] [Abstract][Full Text] [Related]
16. [Antibacterial activities of arbekacin against recently isolated methicillin-resistant Staphylococcus aureus (I)].
Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R
Jpn J Antibiot; 1993 Mar; 46(3):234-41. PubMed ID: 8510320
[TBL] [Abstract][Full Text] [Related]
17. [MRSA infections in surgery].
Fujita K; Suzuki T; Kato H; Nagamachi Y; Okubo T
Jpn J Antibiot; 1994 Jun; 47(6):813-9. PubMed ID: 8072191
[TBL] [Abstract][Full Text] [Related]
18. [Antimicrobial activities of arbekacin against methicillin-resistant Staphylococcus aureus isolated from patients of a pediatrics ward].
Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1993 Sep; 46(9):794-800. PubMed ID: 8254899
[TBL] [Abstract][Full Text] [Related]
19. [Clinical effect of the combined therapy of arbekacin and imipenem/cilastatin against methicillin-resistant Staphylococcus aureus].
Hashimoto A; Ohtsubo T; Tomono K; Kaku M; Koga H; Kohno S; Hara K; Sugiyama H; Taira K; Inoue Y
Jpn J Antibiot; 1994 Jun; 47(6):804-12. PubMed ID: 8072190
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of bactericidal activity of arbekacin in mixed culture with MRSA and Pseudomonas aeruginosa using an in vitro pharmacokinetic simulation system].
Tsuji A; Sugano T; Yamaguchi K; Goto S; Takada T; Takase Y; Yoshida T
Jpn J Antibiot; 1994 Jun; 47(6):655-63. PubMed ID: 8072174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
